Managed Entry Services
Demonstrate Brand Value to the NHS
As the National Health Service (NHS) pursues its collective goal to produce healthcare results that lead the world, it is intensifying its emphasis on a group of far-reaching, critical objectives: reducing mortality and morbidity, increasing safety, and improving patient experience and outcomes. For pharmaceutical manufacturers, that acute focus on outcomes means that they will be measured – and, ultimately, compensated – based on the value for the money that their new medicines offer to discrete patient populations.
Whether first viewed as a business philosophy, a process, or a series of interconnected tactics, Managed Entry Services from Quintiles always point to the same result: A better understanding of the dynamics poised to influence market acceptance, delivered at a time when those insights can inform your launch strategies directed toward successful long-term brand adoption.
